Copyright: ©Author(s) 2026.
World J Gastroenterol. May 7, 2026; 32(17): 116590
Published online May 7, 2026. doi: 10.3748/wjg.v32.i17.116590
Published online May 7, 2026. doi: 10.3748/wjg.v32.i17.116590
Figure 7 Niu Huang attenuates ulcerative colitis by regulating the farnesoid X receptor activation.
A and B: Protein expression level of farnesoid X receptor in colonic tissues (n = 4 in each group); C: Quantitative polymerase chain reaction analysis of the mRNA expression of Nr0b2 and Fgf15 (n = 5 in each group); D and E: Protein expression level of C3 in colonic tissues (n = 4 in each group); F and G: Pearson correlation analysis between C3 and farnesoid X receptor in the sigmoid colon and transverse colon. aP < 0.05 vs dextran sulfate sodium group, bP < 0.01 vs dextran sulfate sodium group. DSS: Dextran sulfate sodium; NHL: Low-dose Niu Huang group; NHH: High-dose Niu Huang group; Mes: Mesalamine group; GADPH: Glyceraldehyde 3-phosphate dehydrogenase; NR1H4: Nuclear receptor subfamily 1 group H member 4.
- Citation: Shi J, Ma CY, Zhang XH, Liu KJ, Liu JY, Wang QG, Wang XQ, Cheng FF, Xu T. Niu Huang mitigates dextran sulfate sodium-induced colitis by modulating farnesoid X receptor activation and the complement 3/NLRP3 signaling pathway. World J Gastroenterol 2026; 32(17): 116590
- URL: https://www.wjgnet.com/1007-9327/full/v32/i17/116590.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i17.116590